SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- HIV
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DewDiligence_on_SI who wrote (85)2/21/2009 9:29:06 PM
From: Elroy Jetson   of 155
 
Combination tablets can also create compliance problems.

A frequent example is a patient with a reduced GFR secondary to Viread usage. In this event Atripla needs to be immediately, yet temporarily, replaced with Sustiva and Epivir for several weeks.

Since the patient often cannot obtain these medications in a timely manner, this results in non-compliance for a period of time. Some Doctors will simply stop the Atripla, due to the extra complications involved, with a worse outcome for their patient.
.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News